Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Study of CIM101 in Lung cancer patients

Trial Profile

Study of CIM101 in Lung cancer patients

Phase of Trial: Phase I

Latest Information Update: 21 Jan 2017

At a glance

  • Drugs CIM 101 (Primary)
  • Indications Lung cancer
  • Focus Adverse reactions
  • Most Recent Events

    • 21 Jan 2017 New trial record
    • 19 Jan 2017 According to a CiMaas media release, this trial is expected to start in 2017.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top